Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study). [electronic resource]
Producer: 20030331Description: 1300-6 p. digitalISSN:- 0002-9149
- Acute Disease
- Anti-Arrhythmia Agents -- therapeutic use
- Atrial Fibrillation -- drug therapy
- Delayed-Action Preparations
- Double-Blind Method
- Endpoint Determination
- Female
- Heart Rate -- drug effects
- Humans
- Male
- Middle Aged
- Propafenone -- therapeutic use
- Proportional Hazards Models
- Recurrence
- Safety
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.